Private Equity
New Enterprise Associates has named life sciences veteran Dr. Elliott Sigal as a venture partner and senior advisor to help augment the firm's healthcare practice. Sigal is a former executive vice president and director for Bristol-Myers Squibb, where he served as the company’s Chief Scientific Officer and president of R&D from 2004 to 2013.
4 min read · 09 January 2014
Trevena has appointed Dr. Francois Nader to its board of directors. Dr. Nader is the president and CEO of NPS Pharmaceuticals.Based in King of Prussia, Penn., Trevena is a clinical stage biopharmaceutical company that develops therapeutics that target G protein coupled receptors. It is backed by Alta Partners, New Enterprise Associates, Polaris Partners, Forest Labs and HealthCare Ventures.
3 min read · 08 January 2014
Vestaron Corp. has named Dr. John Sorenson as its CEO. Dr. Sorenson has been the company's interim CEO since September. Also, Keith Gillard of Pangaea Ventures has been appointed chairman of the board of directors. Based in Kalamazoo, Mich., Vestaron is a producer of pesticides. Its backers include Pangaea Ventures and Open Prairie Ventures.
2 min read · 08 January 2014
Versartis said Wednesday that it has named Jay Shepard as executive chairman to its board of directors. Shepard is currently an executive partner at Sofinnova Ventures. Based in Redwood City, Calif., Versartis is a biotechnology company focused on developing treatments for patients with endocrine disorders.
2 min read · 08 January 2014
The most recent Forbes' 30 Under 30 list points to the youthful energy that is currently powering many venture-backed technology startups. Among those recognized are several notable Canadian company founders, entrepreneurs and investors. Examples include Vancouver's Brian Wong, the founder and CEO of San Francisco-based mobile rewards network Kiip, Eric Migicovsky, the University of Waterloo engineering graduate who launched smart-watch maker Pebble Technology , and Ted Livingston, who helped found Waterloo, Ont.-based KiK Interactive, a developer of mobile messaging applications for smartphones.
1 min read · 07 January 2014
Battery Ventures has named Adrian Cockcroft as a technology fellow. Previously, Cockcroft worked at Netflix where he helped lead the company's shift to an all-cloud computing infrastructure.
2 min read · 07 January 2014
G1 Therapeutics said Tuesday that it has named Dr. Seth Rudnick as executive chairman of its board of directors. The appointment is effective immediately. Dr. Rudnick is recently retired from Canaan Partners. Based in Chapel Hill, North Carolina, G1 is a pharmaceutical company focused on cancer therapy and biodefense applications. It is backed by MedImmune Ventures, Hatteras Venture Partners and Mountain Group Capital.
3 min read · 07 January 2014
CTPartners has hired Robert Wilder as managing partner of Middle East and North Africa. He will be based in the firm's Dubai office. Previously, Wilder worked at Spencer Stuart. Headquartered in New York, with offices all over the world, CTPartners is an executive search firm that serves a wide variety of sectors, including private equity and venture capital.
2 min read · 07 January 2014
Q Factor said Monday that it has named Doug Pasko to its board of advisors. Paskso is a director in the network and technology group at Verizon. Headquartered in Waltham, Mass., Q Factor is a provider of solutions that streamline the delivery of rich media to any device on any network. It is backed by Sigma Prime Ventures and Venrock.
2 min read · 06 January 2014
Kala Pharmaceuticals has named Howard B. Rosen as chairman of its board of directors. Previously, he worked at Pearl Therapeutics where he served as interim president and CEO. Based in Waltham, Mass., Kala Pharmaceuticals is a developer of treatments for ocular diseases. Its backers include Lux Capital, Polaris Venture Partners, Third Rock Ventures and Crown Venture Fund.
4 min read · 06 January 2014
